* IRadimed Corp IRMD.OQ reported quarterly adjusted earnings
of 13 cents per share for the quarter ended in March. The mean
expectation of two analysts for the quarter was for earnings of
10 cents per share.
* Revenue rose 6.3% to $9.22 million from a year ago; analysts
expected $8.56 million.
* IRadimed Corp's reported EPS for the quarter was 11 cents.
* The mean earnings estimate of analysts had fallen by
about 33.3% in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* IRadimed Corp shares had risen by 3.8% this quarter and
gained 17.4% so far this year.
* The company reported quarterly net income of $1.39 million.
* Wall Street's median 12-month price target for IRadimed Corp
is $29.00
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
This summary was machine generated April 30 at 05:23 p.m. GMT.
All figures in US Dollars.